US FDA approves Novo's insulin injection for type 2 diabetes

March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. * Novo Nordisk expects to launch the insulin product in theUnited States in the second half of 2026. * The Danish drugmaker said its product is the "first-ever"once-weekly basal insulin